$4.52
-0.21-4.44%
Last update: Nov 11, 7:38 AM
Precigen Inc
PGENNASDAQ
Precigen rose 14.1% from $3.96 to $4.52, ahead of the S&P 500's +9.8%. Its worst day was Nov 2 (−25.9%), and its low came Mar 25 at $3.10.
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-1.06 missed the $-0.09 estimate on $2.9M revenue (est. $500,000.00).
+25.6%, the year's best day · S&P 500 0.0%
Story events cover the past 12 months · Times ET
EPS of $-0.01 beat the $-0.09 estimate on $4.6M revenue (est. $7.2M).
+25.5% · S&P 500 −1.8%
EPS of $-0.02 beat the $-0.04 estimate on $23.3M revenue (est. $20.9M).
+10.8% · S&P 500 +0.8%
Precigen shares rose 16.5%, while the S&P 500 rose 1.7%.
+16.5% · S&P 500 +1.7%
EPS of $0.05 beat the $-0.01 estimate on $55.0M revenue (est. $27.8M).
+5.5% · S&P 500 −0.2%
Precigen closed at its highest level of the year, 116.2% above where the year started.
+6.3% · S&P 500 −0.2%
EPS of $0.08 beat the $0.08 estimate on $74.1M revenue (est. $72.3M).
−16.5%, on 27M shares, the year's heaviest volume · S&P 500 −4.4%
Where it ended: a close of $4.52 on Nov 10, 2026.
Nothing in the past 12 months.
All PGEN dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for PGEN and SPY from Benzinga historical bars. Not investment advice.
